Filed before 2025Filed 11 October 2022
Elysium Therapeutics, Inc. has sold $2.23M so far
Elysium Therapeutics, Inc., a biotech company based in Akron, OH, has sold $2.23M so far in its equity round, according to a filing dated 11 October 2022.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 11 October 2022
- First filed
- 16 November 2020
- Round
- Equity round (amended filing)
- Amount sold
- $2.23M
- Offering size
- $9.13M
- Investors so far
- 30
- Based in
- Akron, OH
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 16% of the 1,764 tracked raises with an amount filed in 2022, and than 14% of the 142 in biotech.
Elysium Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 11 Oct 2022 | Amended filing | $2.23M | This raise |
| 16 Nov 2020 | New filing | $915K | This raise |
More with Mesa Verde on the board
- MatriSys Bioscience, Inc.$8.4M
- ViaCyte Inc.$53.9M
- AltheaDx, Inc.$3.73M
- HCW Biologics Inc.$6.17M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.